Given the patient's history of breast cancer and long-term use of aromatase inhibitors, one might also consider whether endocrine or paraneoplastic factors could have influenced retinal degeneration, though this remains speculative and undocumented. This evidence concerns the gene CYP19A1 and breast carcinoma.